The Case for Eliminating Racial and Ethnic Cardiovascular Disparities in the USA
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Achieving equitable access to incretin-based therapies in cardiovascular care.
Reddy T, Villavaso C, Pulapaka A, Ferdinand K Am Heart J Plus. 2024; 46:100455.
PMID: 39315291 PMC: 11417191. DOI: 10.1016/j.ahjo.2024.100455.
Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults.
Reddy T, Nasser S, Pulapaka A, Gistand C, Ferdinand K Curr Cardiol Rep. 2024; 26(11):1163-1171.
PMID: 39235728 PMC: 11538188. DOI: 10.1007/s11886-024-02115-5.
References
1.
Bor J, Stokes A, Raifman J, Venkataramani A, Bassett M, Himmelstein D
. Missing Americans: Early death in the United States-1933-2021. PNAS Nexus. 2023; 2(6):pgad173.
PMC: 10257439.
DOI: 10.1093/pnasnexus/pgad173.
View
2.
Abdalla M, Bolen S, Brettler J, Egan B, Ferdinand K, Ford C
. Implementation Strategies to Improve Blood Pressure Control in the United States: A Scientific Statement From the American Heart Association and American Medical Association. Hypertension. 2023; 80(10):e143-e157.
PMC: 10578150.
DOI: 10.1161/HYP.0000000000000232.
View
3.
Amrock S, Duell P, Knickelbine T, Martin S, OBrien E, Watson K
. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry. Atherosclerosis. 2017; 267:19-26.
DOI: 10.1016/j.atherosclerosis.2017.10.006.
View
4.
Myers K, Farboodi N, Mwamburi M, Howard W, Staszak D, Gidding S
. Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes. Circ Cardiovasc Qual Outcomes. 2019; 12(8):e005404.
PMC: 7665275.
DOI: 10.1161/CIRCOUTCOMES.118.005404.
View
5.
He J, Bundy J, Geng S, Tian L, He H, Li X
. Social, Behavioral, and Metabolic Risk Factors and Racial Disparities in Cardiovascular Disease Mortality in U.S. Adults : An Observational Study. Ann Intern Med. 2023; 176(9):1200-1208.
PMC: 11149775.
DOI: 10.7326/M23-0507.
View